The objective of this study is to assess the efficacy of an implantable etonogestrel device in reducing hysterectomy rate in patients with a failed endometrial ablation.
The researchers aim to determine whether use of etonogestrel implant in patients with failed endometrial ablation significantly decreases hysterectomy rate. Changes in pelvic pain and vaginal bleeding will be assessed. Time to hysterectomy will be examined. The researchers hypothesize that treatment of failed endometrial ablation with etonogestrel implant will decrease pelvic pain and vaginal bleeding resulting in a significantly decreased need for hysterectomy.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Implant will be inserted
Implant will be inserted
Saskatchewan Health Authority
Regina, Saskatchewan, Canada
Hysterectomy
occurrence of hysterectomy
Time frame: Occurrence of hysterectomy will be documented any time during the 3 year follow up period
Vaginal bleeding
Pictorial Blood Loss Assessment Chart (PBAC) score, minimum score = 0mL, maximum score = n/a, higher score indicates higher menstrual blood loss
Time frame: PBAC score will be documented at baseline and 3, 6, 12, 18, 24, 30, and 36 months
Pelvic Pain
Assessment of pelvic pain using Visual Analogue Scale (VAS), minimum score = 0, maximum score = 10, higher score indicates more pain
Time frame: VAS will be documented at baseline and 3, 6, 12, 18, 24, 30, and 36 months
Time to Hysterectomy
Time from booking of hysterectomy to actual hysterectomy will be documented
Time frame: Time of hysterectomy will be documented any time during the 3 year follow up period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.